Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S5W-19706 · Session 5

What assurances it can provide that patients in Scotland will have the same access to medicinal cannabis as those in the rest of the UK.

Answered Asked by John Finnie Green Lodged 1 Nov 2018

The question

To ask the Scottish Government what assurances it can provide that patients in Scotland will have the same access to medicinal cannabis as those in the rest of the UK.

The answer

Answered by Jeane Freeman on 8 Nov 2018 · 7 days after it was lodged, on time

Regulation for the control of drugs under the Misuse of Drugs Act 1971 is currently the responsibility of the UK Government. The regulatory changes which came into force on 1 November 2018 to reschedule Cannabis Based Products for Medicinal Use in Humans apply in England, Wales and Scotland.
Moving cannabis-based products for medicinal use from Schedule 1 to Schedule 2 of the Misuse of Drugs Regulation 2001 means those cannabis-based products can be prescribed where there is an unmet clinical need. Guidance was issued to professionals in Scotland via a letter from the Chief Medical Officer (SGHD/SMO(2018) 15) on 31 October.

In the Official Report

No contribution in the Official Report cites S5W-19706 by reference.